Related Experiment Video
Updated: Jul 26, 2025

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
Live Biotherapeutic Products as Cancer Treatments
Arianna Brevi1,2, Amir Zarrinpar1,2,3,4
1Division of Gastroenterology, University of California, La Jolla, San Diego, California.
Abstract:
Almost every aspect of cancer can be influenced by microbiota including tumor onset, progression, and response to therapy. The increasing evidence of the role of microbiota in human health and disease has reinvigorated the interest in designing microbial products that can affect cancer outcomes. Researchers have made numerous attempts to develop safe, engineered biotherapeutic products for cancer treatment using synthetic biology tools. Despite the progress, only Bacillus Calmette-Guérin is approved for human use. Here, we highlight the recent advances and current challenges in using live bacteria as cancer therapeutics.
Insights
The human microbiota influences cancer development and treatment response. Researchers are developing engineered live bacteria as cancer therapeutics, but challenges remain for clinical application.
Area of Science:
- Microbiology
- Oncology
- Synthetic Biology
Background:
- The human microbiota plays a significant role in various aspects of cancer, including its onset, progression, and response to therapies.
- Growing evidence highlights the impact of microbiota on human health and disease, stimulating interest in microbial-based cancer treatments.
Purpose of the Study:
- To review recent advancements in the development of live bacteria as cancer therapeutics.
- To discuss the current challenges and future directions in engineering microbial products for cancer treatment.
Main Methods:
- Review of current literature on synthetic biology applications in developing bacterial cancer therapeutics.
- Analysis of progress and limitations in translating engineered bacteria into clinical cancer treatments.
Main Results:
- Significant progress has been made in designing engineered biotherapeutic products using synthetic biology tools.
- The field faces challenges in ensuring the safety and efficacy of live bacterial therapeutics for human use.
Conclusions:
- Live bacteria hold promise as a novel approach to cancer therapy.
- Further research and development are needed to overcome existing hurdles for the clinical application of engineered microbial therapeutics.
More Related Videos
08:50Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
Published on: August 16, 2024
13:17In Vitro and In Vivo Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology
Published on: September 29, 2023
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...